A SPAC deal announced Monday could help accelerate the manufacturing of a promising weight loss drug targeting over 150 million people. Public CPSR shareholders will own 21% of the company after the ...
First came the "edible billboard," which appeared last year during the holidays in New York's East Village loaded with cake treats. Then, in late January, came the national marketing campaign, with TV ...
Share on Pinterest Experts say weight loss medications can be effective if combined with healthy lifestyle choices. Kateryna Onyshchuk/Getty Images A weight-loss medication called Plenity is now ...
Overweight and obese people will soon have a new medical option to help them manage their weight. On Monday, the Boston biotech company Gelesis announced they had received clearance from the Food and ...
First came the "edible billboard," which appeared last year during the holidays in New York's East Village loaded with cake treats. Then, in late January, came the national marketing campaign, with TV ...
BOSTON--(BUSINESS WIRE)--Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) the maker of Plenity for weight management, today announced Dr. Frank Greenway will give an oral presentation at ...
WASHINGTON, D.C. (WPVI) -- The Food and Drug Administration has cleared the sale of a new type of weight loss product - one designed to make you more full at meal time. Plenity is a prescription ...
Public listing of Gelesis, along with Karuna Therapeutics (Nasdaq: KRTX) and Vor Biopharma (Nasdaq: VOR), five other private Founded Entities and advanced Wholly Owned Pipeline, further exemplifies ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results